Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia

Leukemia and Lymphoma

Volumn 56, Issue 3, 2015, Pages 782-784

  Ueda, Masumi ^a   Xie, Hu ^b   Sandhu, Ravinder K ^b   Walter, Roland B ^a,b   Pagel, John M ^b   Estey, Elihu H ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

ACUTE DISEASE; ADULT; AGED; BONE MARROW EXAMINATION; CANCER STEM CELL; CELL COUNT; DRUG EFFECTS; HUMAN; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID; MIDDLE AGED; PATHOLOGY; PROCEDURES; REMISSION; RETREATMENT; TIME FACTOR;

ACUTE DISEASE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW EXAMINATION; CELL COUNT; CYTARABINE; HUMANS; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASTIC STEM CELLS; REMISSION INDUCTION; RETREATMENT; TIME FACTORS;

EID: 84924751841     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.928931     Document Type: Letter

References (4)

1. O'Donnell MR, Abboud CN, Altman J, et al. Acute myeloid leukemia. J Natl Compr Canc Netw 2012;10:984-1021.
2. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000;96:4075-4083.
3. Hussein K, Jahagirdar B, Gupta P, et al. Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol 2008;83:446-450.
4. Othus M, Sudipto M, Sekeres M, et al. Prediction of CR on reinduction in patients with newly diagnosed acute myeloid leukemia given intensive induction regimens: a report from SWOG and Cleveland Clinic. Blood 2013;122(Suppl. 1): Abstract 3924.